A Gene Editing Therapy Cut Cholesterol Levels by Half

A Gene Editing Therapy Cut Cholesterol Levels by Half thumbnail

An experimental gene-editing therapy developed by Crispr Therapeutics is showing promise for treating heart disease.

LEAVE A REPLY

Your email address will not be published. Required fields are marked *